Medical supplier Biomerics expands Minnesota plant

Medical device contract manufacturer Biomerics L.L.C. has expanded its Brooklyn Park, Minn. facility by 100,000 square feet to meet increased demand for medical extrusions and catheters.

"This expansion consolidates all Biomerics' Minnesota operations under one roof," Tom Winegar, president of Biomerics Brooklyn Park, said in a Sept. 22 news release. "This allows for a one-stop shop for our customers to meet their design and manufacturing needs for micro metals processing, advanced extrusion, product development, advanced catheters and advanced steerables."

It includes 20,000 square feet of expanded micro metals laser processing; 24,000 square feet of complex extrusion processing, 2,000 square feet of that is a certified ISO class 8 clean room space; and 10,000 square feet of advanced catheter processing, the release said. The expansion also includes additional employee training and office space.

"I'm thrilled to continue to see our vertical integration on full display throughout our growing global operations," Travis Sessions, CEO of Biomerics, said in the release."

Biomerics did not respond to requests for comment by Plastics News, a Rubber News sister publication.

This new space allows the company to triple its extrusion output over the next five years, the release said.

The Brooklyn Park extrusion and catheter teams will collaborate with Biomerics' custom proprietary polyurethane manufacturing team in Salt Lake City on proprietary thermoplastic materials and compounds for medical tubing, the company said.

"The expansion significantly scales our capabilities for our customers as they grow," Chris Richardson, president of Biomerics' advanced interventional catheter, added.

In July, Biomerics merged with Precision Concepts Medical, a portfolio business of Toronto-based buyout fund ONCAP IV.

Salt Lake City-based Biomerics L.L.C. provides engineering design, technology transfer manufacturing, and contract manufacturing, including sterilization and packaging, for medical device components, subassemblies and finished medical devices at nine locations in the United States, two in Costa Rica, one in the Dominican Republic and one in Ireland.